Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS)
- PMID: 26323992
- DOI: 10.1007/s00401-015-1471-7
Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS)
Abstract
Progressive multifocal leukoencephalopathy is a viral encephalitis induced by the John Cunningham (JC) virus, an ubiquitous neurotropic papovavirus of the genus polyomavirus that in healthy people in latency resides in kidney and bone marrow cells. Activation and entry into the CNS were first seen in patients with malignancies of the hematopoietic system and an impaired immune system. During the 1980 and the 1990s with the appearance of human immunodeficiency virus infection in humans, PML was found to be the most important opportunistic infection of the central nervous system. As a result of highly efficient immunosuppressive and immunomodulatory treatments, in recent years, the number of PML cases again increased. PML is prevented by an intact cellular immune response and accordingly immune reconstitution can terminate established disease in the CNS. However, forced immune reconstitution can lead to massive destruction of virus-infected cells. This may result in clinical exacerbation associated with high morbidity and mortality and referred to as PML with immune reconstitution inflammatory syndrome (PML-IRIS). In the present review, we discuss virological properties and routes of infection in the CNS, but mostly focus on the pathology of PML and PML-IRIS and on the role of the immune system in these disorders. We show that PML and PML-IRIS result from predominant JC virus infection of oligodendrocytes and, to a lesser extent, of infected neurons. Inflammation in these encephalitides seems to be driven by a dominant cytotoxic T cell response which is massively exaggerated during IRIS.
Keywords: Immune reconstitution inflammatory syndrome; JC virus; Neuropathology; Progressive multifocal leukoencephalopathy; T cell cytotoxicity.
Similar articles
-
Progressive multifocal leukoencephalopathy.J Neuroimmunol. 2011 Feb;231(1-2):73-7. doi: 10.1016/j.jneuroim.2010.09.021. J Neuroimmunol. 2011. PMID: 20937530 Review.
-
Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.Ann Neurol. 2016 Mar;79(3):404-18. doi: 10.1002/ana.24574. Epub 2016 Feb 13. Ann Neurol. 2016. PMID: 26874214
-
Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.Front Immunol. 2019 May 28;10:1188. doi: 10.3389/fimmu.2019.01188. eCollection 2019. Front Immunol. 2019. PMID: 31191548 Free PMC article.
-
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.Lancet Neurol. 2010 Apr;9(4):425-37. doi: 10.1016/S1474-4422(10)70040-5. Lancet Neurol. 2010. PMID: 20298966 Free PMC article. Review.
-
Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome.Brain. 2011 Sep;134(Pt 9):2687-702. doi: 10.1093/brain/awr206. Brain. 2011. PMID: 21908874
Cited by
-
Progressive Multifocal Leukoencephalopathy and Immune Reconstitution Inflammatory Syndrome after Discontinuation of Fingolimod.Case Rep Neurol. 2022 Feb 7;14(1):38-43. doi: 10.1159/000521944. eCollection 2022 Jan-Apr. Case Rep Neurol. 2022. PMID: 35350291 Free PMC article.
-
To Go or Stay: The Development, Benefit, and Detriment of Tissue-Resident Memory CD8 T Cells during Central Nervous System Viral Infections.Viruses. 2019 Sep 11;11(9):842. doi: 10.3390/v11090842. Viruses. 2019. PMID: 31514273 Free PMC article. Review.
-
Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis.Acta Neuropathol. 2017 Apr;133(4):613-627. doi: 10.1007/s00401-016-1642-1. Epub 2016 Nov 5. Acta Neuropathol. 2017. PMID: 27817117 Free PMC article.
-
Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.Cell Rep. 2017 Oct 31;21(5):1169-1179. doi: 10.1016/j.celrep.2017.10.027. Cell Rep. 2017. PMID: 29091757 Free PMC article.
-
Interleukin-15 superagonist (N-803) treatment of PML and JCV in a post-allogeneic hematopoietic stem cell transplant patient.Blood Adv. 2020 Jun 9;4(11):2387-2391. doi: 10.1182/bloodadvances.2019000664. Blood Adv. 2020. PMID: 32484854 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials